Three independent discounted-cash-flow-style models value MiMedx Group, Inc every trading day. 0 of 3 currently price MDXG above its market price.
| Free Cash Flow model | $-1.99 |
| Excess Profit model | $2.83 |
| Residual Earnings model | $0.92 |
| Dividend Discount model | — |
| Piotroski F-Score | 6 / 9 |
| Return on invested capital | +18.4% |
| Net debt / EBITDA | -2.3× |
| Gross margin | +82.6% |
| Revenue CAGR | +16.1% |
| Cash conversion | 1.5× |
| Dividend yield | — |
| Buyback yield | -0.6% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open MDXG in StockKitty